Introduction

Legionnaires’ disease in pneumonic form and Pontiac fever were first recognised in 1976. Since then, the number of cases of Legionnaires’ disease has increased worldwide, particularly in the United States (https://www.cdc.gov/legionella/surv-reporting.html) and Europe (http://ecdc.europa.eu/en/data-tools/Pages/home.aspx). In Japan, the number of cases doubled between 2010 and 2015 (http://www.nih.go.jp/niid/ja/data.html). However, the number of patients is thought to be under-reported1 because the early symptoms of Legionnaires’ disease are similar to those of a common cold and quite number of patients are treated by empirical chemotherapy without diagnostic confirmation as Legionnaires’ disease2.

Legionnaires’ disease is often referred to as ‘traveller’s disease’ with the rise in domestic and international travel. Surveillance for this travel-associated disease has increased in the United States and Europe. Being a volcanic country, Japan has many spa resorts with hot springs. Many Japanese and foreign travellers visit and enjoy a culture of bathing in these hot springs. However, not a few of these spa facilities use filtration and circulation systems for the bathing water, and these artificial systems often cause an increase in Legionella cells following the increase in free-living amoebas in the systems3. In July 2002, a large outbreak of Legionnaires’ disease occurred in a bathhouse with spa facilities in Miyazaki Prefecture, Japan4, 5. About 300 patients suffered pneumonia and/or symptoms of fever and a cough, with seven fatalities. This outbreak also caused serious economic damage to the resort area.

It is worth noting that 75–80% of patients with Legionnaires’ disease are over 50 years of age (http://www.who.int/mediacentre/factsheets/fs285/en/), and therefore it is assumed that the number of patients will increase in accordance with aging of the population in many developed countries.

There have been 60 species of Legionella reported to date, which have comprised 70 distinct serogroups6; however, Legionella pneumophila is the predominant species (>90% of cases) isolated from patients with Legionnaires’ disease7. Among the 16 serogroups of L. pneumophila, the primary serogroup associated with outbreaks is serogroup 1 (http://www.who.int/water_sanitation_health/emerging/legionella.pdf). The most common form of transmission of L. pneumophila is inhalation of contaminated aerosols, which may occur from cooling towers, public fountains, water distribution systems and baths that circulate water8. Therefore, the microbial management of these systems is vital in preventing outbreaks linked to poorly maintained artificial water systems. Culture-dependent methods, such as ISO 11731, are usually employed to detect Legionella cells in samples; however, these methods require 10–14 days to obtain results and cannot detect viable but non-culturable (VBNC) Legionella cells9. In addition, the presence of other bacteria interferes with Legionella growth on media and can result in underestimation of the presence of Legionella cells10, 11. Therefore, rapid quantitative methods, which do not rely on culturing, are required to enumerate Legionella cells, and gene-targeting techniques such as PCR are now widely applied. However, these techniques require extraction of DNA or RNA, which is rather difficult to perform in the field. Instead, L. pneumophila cells can be rapidly and accurately detected by culture-independent techniques at a single cell level, such as flow cytometry following immunomagnetic separation and fluorescent staining12, 13, and on-site monitoring of Legionella cells would be effective for the microbial management of artificial water systems, the most common sites of Legionella outbreaks.

A microfluidic device is a small device containing microchannels that has been developed during decades of progress in microfabrication technologies. Microfluidic device-based analyses are rapid and are performed on a smaller scale, thereby consuming less sample and reagents than conventional approaches14; thus these devices have great potential in environmental microbiology15,16,17,18. Microfluidic devices can reduce the biohazard risk because cells are analysed in a closed system and the devices are immediately sterilised after use, making these devices suitable for application in public and environmental health microbiology settings. However, most microfluidic devices have been developed to separate target microbes19, 20 or analyse their characteristics rather than to determine the total number of target microbes21.

In this study, we applied our microfluidic device22 to enumerate L. pneumophila cells in cooling tower water. This microfluidic device was originally designed for on-chip fluorescent staining and semi-automated counting of target microbial cells. We also constructed a portable system for rapid on-site monitoring of L. pneumophila in the water samples and used it to enumerate target microbial cells rapidly flowing in the microchannel.

Results and Discussion

Legionella cells in freshwater are usually detected using culture-dependent techniques such as ISO 11731; however, it can take 10–14 days to obtain results, and Legionella cells in a VBNC state cannot be detected. One approach to solve this problem is to develop new protocols to culture these hard-to-culture Legionella cells11. Another approach is to develop culture-independent techniques that can rapidly detect an increase in Legionella cells and also estimate the microbiological properties of freshwater that is potentially contaminated by L. pneumophila 12, 13, 23. We therefore investigated the possibility of combining a microfluidic device with a portable system for rapid on-site monitoring of L. pneumophila in cooling tower water.

Concentration of low-abundance L. pneumophila cells in cooling tower water samples

The number of L. pneumophila cells in freshwater is usually not high enough for detection. In Japan, the control limit of L. pneumophila in cooling tower water is 100 colony-forming units (CFU)/100 ml (2) and the concentration of the cells is usually required. In addition, one of the cooling tower water samples collected in this study (Supplementary Fig. S1B) contained algal cells and detritus that clogged the flow in the microchannel of the microfluidic device (Supplementary Fig. S2). Therefore, for reliable enumeration of Legionella cells in cooling tower water, these inhibitors need to be removed and Legionella cells need to be concentrated in the sample. By incorporating the following steps: (i) pre-filtration with a 3-μm-pore-size filter, (ii) concentration of the filtrate with a 0.2-μm-pore-size polycarbonate filter, and (iii) resuspension in particle-free water, the recovery rates of L. pneumophila ATCC 33152 and L. pneumophila isolated from cooling tower water (L. pneumophila CT1 A-1) inoculated into cooling tower water as 103 cells/ml were 82 ± 14% (n = 5) and 76 ± 24% (n = 5), respectively. Algal cells and detritus in the sample were effectively removed (Supplementary Fig. S2). However, by incorporating the following steps–(i) concentration with a 0.2-μm-pore-size polycarbonate filter, (ii) resuspension of trapped aggregates on the filter in particle-free water, and (iii) filtration with a 3-μm-pore-size filter—the recovery rate of inoculated Legionella cells decreased to below 40% (31 ± 14%; n = 5). This may be explained by the fact that Legionella cells adsorbed onto algal cells and/or detritus in the cooling tower water during concentration and were then removed together by filtration with the 3-μm-pore-size filter. We therefore proposed the following protocol for effective concentration of Legionella cells and removal of inhibitors: first, pre-filtration of 0.5–3 L of the sample with a 3-μm-pore-size filter; then concentration of the bacterial cells in the filtrate onto a 0.2-μm-pore-size polycarbonate filter; and finally resuspension of the bacterial cells trapped on the filter in 3 ml of particle-free water by vortexing for 1 min.

On-chip staining and enumeration of L. pneumophila cells

Next, the possibility of on-chip staining of L. pneumophila cells with a fluorescent antibody was examined using the originally-designed microfluidic device for on-chip staining and counting (Fig. 1). It was confirmed that the sample and fluorescent antibody solution flowed separately in the microchannel at first (Fig. 1(i)); however, these solutions became mixed during flow through the “mixing part” of the microchannel (Fig. 1(ii)). Sheath fluid was effective for alignment of the flowing bacterial cells (Fig. 1(ii)), and antibody-labelled cells could be detected in the “detecting part” (Fig. 1(iii)).

Figure 1
figure 1

Detail of the microfluidic device for on-chip staining and counting Long and short lengths are 50 mm and 25 mm, respectively. Width of the channel is 100 μm, with the exception of the “mixing part” (500 μm). Depth of the channel is 15 μm. Sample, fluorescent dye solution and sheath fluid were injected at each inlet. The process of on-chip staining and counting of bacterial cells is shown and includes: (i) the sample and fluorescent dye solution flowing separately and becoming mixed in the “mixing part” of the microchannel, (ii) alignment of the sample flow by the sheath fluid, and (iii) the flow of bacterial cells in the “detecting part” of the microchannel.

For the enumeration of fluorescently-stained cells that were flowing through the microchannel of the microfluidic device, a portable system was designed and constructed (Fig. 2). This system consisted of three component parts for i) solution application (syringe pump), ii) detection (optical system with a diode laser, a filter block and a CCD camera), and iii) analysis (laptop). The system was packed into a carry case (final size: 54-cm width, 36-cm depth and 23-cm height; final weight: 15 kg). A diode laser was selected to obtain a bright blue beam of low voltage, for excitation of the fluorescently-labelled bacterial cells. This system can be set at the sampling point for rapid on-site monitoring of target bacterial cells (Supplementary Fig. S3(i)).

Figure 2
figure 2

Portable microfluidic system for on-site bacterial monitoring.

The concentration of fluorescent antibody for on-chip staining was optimised with 1 × 105 cells/ml of L. pneumophila cells spiked in PBS. The microfluidic count was (9.2 ± 1.8) × 104 cells/ml when 20 μg/ml of fluorescent antibody was used (n = 5), compared with (7.3 ± 2.6) × 104 and (8.5 ± 2.9) × 104 cells/ml when 10 and 50 μg/ml of fluorescent antibody were used, respectively. Therefore, 20 μg/ml of fluorescent antibody was selected for use in the following experiments.

Using this microfluidic device and portable system, the correlation between microfluidic counts and conventional fluorescent microscopic counts was determined for samples that contained L. pneumophila within the range of 101 to 106 cells/ml (Supplementary Table S1), and the counts of Legionella cells obtained by the system and by fluorescence microscopy closely correlated (Fig. 3). The detection limit of the microfluidic technique (104 cells/ml) could be improved to 101 cells/ml by concentration of L. pneumophila cells by filtration and resuspension in particle-free water with the procedure determined in this study. The maximum threshold for detection was 106 cells/ml because some of these cells were not accurately counted by the portable system if too many cells (>106 cells/ml) flowed rapidly in the microchannel of the device.

Figure 3
figure 3

Correlation between microfluidic counts and conventional fluorescence microscopic counts of L. pneumophila stained with a fluorescent antibody. Cultured L. pneumophila cells were spiked in cooling tower water. Error bars indicate the standard deviation (n = 5). Samples with 101 cells/ml of Legionella cells were counted following 1000-fold concentration by filtration. Samples with 102 and 103 cells/ml of Legionella were 100-fold concentrated before counting, and samples with 104 to 106 cells/ml of Legionella were counted without concentration.

Monitoring of L. pneumophila in cooling tower water using a microfluidic system

Following the confirmation of accuracy of the portable microfluidic system to enumerate L. pneumophila cells at low abundance, monitoring of L. pneumophila in cooling tower water was performed.

First, the accuracy of the microfluidic counts determined by the microfluidic device for on-chip staining and counting was evaluated by the desktop microfluidic system previously developed in our laboratory (Supplementary Fig. S4)24 because the sensitivity of this previous system was higher than the portable microfluidic system constructed in this study. Cooling tower water samples were collected at the cooling tower (A) (Supplementary Fig. S1) and L. pneumophila cells in the samples were concentrated by filtration and resuspended in particle-free water as previously described. The microfluidic counts were similar with the fluorescent microscopic counts (Supplementary Fig. S5) and we confirmed that the microfluidic device for on-chip staining and counting can be used for efficient counting of L. pneumophila cells not only in spiked samples but also in natural water samples.

Then monitoring of L. pneumophila in cooling tower water was performed by the combined use of the microfluidic device for on-chip staining and counting and the portable microfluidic system (Fig. 4). Cooling tower water samples were collected at the cooling tower (B) (Supplementary Fig. S1). The existence of Legionella spp. in these cooling tower water samples was confirmed using a loop-mediated isothermal amplification kit. The number of culturable L. pneumophila was found to be 30–4800 CFU/ml during the monitoring period, which was 0.22–40.7% that of the microfluidic counts, and this lack of correlation was consistent with previous studies using culture-independent techniques10, 12. This is likely because fluorescent staining methods can detect L. pneumophila cells in the VBNC state whereas culture-dependent methods cannot13. It was revealed that the L. pneumophila cell count decreased during continuous work and disinfection (from 12 July to 25 August); however, it increased after intermittent circulation of the cooling tower water was performed and the frequency of disinfection was decreased (after 21 September). Increase and decrease of L. pneumophila cells could be monitored by the portable microfluidic system as well as conventional fluorescence microscopy, and the results were obtained within 1.5 h (1 h for pre-filtration of cooling tower water and concentration of Legionella cells and 30 min for on-chip staining and counting by the portable system). These results indicated that rapid and accurate counting of L. pneumophila cells in cooling tower water can be performed and appropriate microbiological control of cooling tower water can be confirmed on-site by the combined use of the microfluidic device and the portable system described in this study. Furthermore, combination of this system with an electric vehicle would expand its usefulness because it would enable easy transport of the system to a monitoring site and provide a highly energetic electric power supply outside of a laboratory (Supplementary Fig. S3(ii)).

Figure 4
figure 4

Monitoring of L. pneumophila in cooling tower water by fluorescence microscopy and the portable microfluidic system.

We constructed our microfluidic device using rapid prototyping and replica-moulding techniques24; however, it is now possible to construct such devices using a consumer-grade 3D printer25, making this type of technology more readily accessible.

Conclusion

In this study, we applied a microfluidic device and a portable system to address a problem in the field of public and environmental health microbiology. Our technique effectively enumerated total L. pneumophila cells without culturing and could therefore be applied for “first screening” purposes in the microbial quality control of cooling tower water and other freshwater potentially contaminated by Legionella cells. In this study, we used a polyclonal antibody for detection of L. pneumophila. One limitation of this method is that the polyclonal antibody may react with other serogroups of L. pneumophila and other Legionella species, and potentially other bacterial species. However, as an initial screening method, avoiding false-negative results is more important than the detection of false-positive cells, and using a polyclonal antibody is therefore permissible. To more specifically detect target cells, an appropriate monoclonal antibody could be selected that would attach to unique epitopes on the target bacterial surface12.

Our technique offers the following advantages: (i) rapid performance (1.5 h to complete); (ii) ease of use as a semi-automated system (for on-chip staining and counting); and (iii) portability for on-site measurement. A specific feature of this system that differs from gene-targeting techniques26,27,28 or electrochemical detection techniques29 is that it can visualise Legionella cells in the sample. By watching a video of the flow in the microchannel and recognising the frequency of flowing Legionella cells, one can directly grasp the increase or decrease in target cells even without having specialist microbiology knowledge. For example, one can recognise the increase of L. pneumophila cells when the frequency of flowing cells in the microchannel increases to 10 cells/min from the more regular level of 1 cell/min. This feature is important for the rapid examination of Legionella cells in environmental samples. In addition, fluorescent vital staining30 can be applied in our system to distinguish between live and dead Legionella cells, though this would require a colour-sensitive CCD camera with high-resolution for reliable detection. Viable L. pneumophila cells can be successfully distinguished from non-viable cells by combination of a nucleic acid-staining dye (SYBR Green) with propidium iodide, which can be used to detect membrane-damaged cells13. If a combination of 5-cyano-2,3-ditolyl tetrazolium chloride (CTC) to detect respiring cells31, and green fluorescently-labelled antibody to detect target cells, is applied (double staining with fluorescent antibody and CTC)32, active Legionella cells show orange fluorescence (as a result of mixing the green fluorescence from the fluorescent antibody and the red fluorescence from CTC) under blue excitation, whereas inactive Legionella cells show only the green fluorescence of the fluorescent antibody. Respiring bacterial cells other than L. pneumophila show only the red fluorescence of CTC, meaning that it is possible to distinguish active Legionella cells from inactive Legionella cells or active non-Legionella cells based on their fluorescence32.

When enumerating L. pneumophila cells, a greater number of inhibitors are present in cooling tower water than in other sources of freshwater, such as public fountains, bathtub water or water distribution systems, indicating that our technique may be successfully applied to these other types of environmental water samples. In fact, our technique could detect L. pneumophila cells in a natural river located in Kagoshima Prefecture, Japan, where discharged hot spring water and cold river water were mixed and pooled (Supplementary Fig. S6)33. Also, our technique could detect L. pneumophila cells in circulating bathtub water samples (Supplementary Fig. S7)34 that contained scurf and water scale (different inhibitors from cooling tower water for detection). In addition, our technique can be used to monitor various harmful bacteria by incorporating a suitable fluorescent antibody for the target bacteria. We therefore propose that our findings contribute towards technical progress in developing effective quality control systems for various sources of freshwater used for human consumption, recreation, food preparation and industry35,36,37.

Materials and Methods

Bacterial strains and cooling tower water

Legionella pneumophila ATCC 33152 and L. pneumophila CT1 A-1 (isolate from the cooling tower (B) in Supplementary Fig. S1) were cultured on WYOα agar media (Eiken Chemical, Tokyo, Japan). Resulting colonies were suspended in phosphate-buffered saline (PBS; 130 mM NaCl, 10 mM Na2HPO4, 10 mM NaH2PO4; pH 7.2) within the range of 101 to 106 cells/ml and were used in this study. The numbers of L. pneumophila cells suspended in PBS were determined by fluorescence microscopy as described later. To enumerate Legionella cells using the portable microfluidic system, samples containing 101 cells/ml of Legionella cells were 1000-fold concentrated by filtration before counting, samples with 102 and 103 cells/ml of Legionella cells were 100-fold concentrated, and 104 to 106 cells/ml of Legionella cells were counted without concentration.

Cooling tower water samples were collected at a cooling tower located in Osaka, Japan (Supplementary Fig. S1). Cooling tower (A) was in operation throughout the year whereas cooling tower (B) was only in operation periodically. Cooling tower (B) started work on 1 July, 2016 and the cooling tower water was disinfected once a week during operation. Intermittent circulation of the cooling tower water was performed from 19 September, 2016 and the frequency of disinfection was decreased after this intermittent circulation.

Before staining of L. pneumophila cells in the cooling tower water with a fluorescent antibody, 0.5–3 L of water sample were filtered through a 3-μm-pore-size cellulose acetate filter (Advantec, Tokyo, Japan) to remove algal cells and detritus that may inhibit the flow of bacterial cells in the microchannel. Bacterial cells in the filtrate were then concentrated onto a 0.2-μm-pore-size polycarbonate filter (Advantec) by filtration and resuspended in 3 ml of particle-free water by vortexing for 1 min. This procedure was based on the official method used in Japan2 to concentrate and recover L. pneumophila cells in cooling tower water.

Detection of L. pneumophila in cooling tower water

Culturable L. pneumophila cells were detected according to the procedure described in the Guideline for Prevention of Legionnaires’ Disease 3rd Version2. This procedure was based on ISO 11731. Bacterial cells in 500 ml of cooling water sample were filtered through a 0.2-μm-pore-size polycarbonate filter (Advantec) and resuspended in 5 ml of sterilised deionised water by vortexing for 1 min. This concentrate was treated by acidification under pH 2.0 for 5 min at room temperature (approximately 25 °C) or by heating at 50 °C for 30 min, and then 0.2 or 0.1 ml of the sample was smeared onto WYOα agar medium. After incubation at 37 °C for 7 days, colonies that had formed on the WYOα agar medium were transferred to B-CYEα agar medium (Eiken Chemical) and sheep blood agar (Eiken Chemical) and then incubated for 3 days at 37 °C for confirmation of L. pneumophila cells by an agglutination test kit (Legionella Latex Test; Denka Seiken, Tokyo, Japan), which is used as an official test in Japan2. The detection limit of this culture method was 10 CFU/100 ml of the tested water sample.

Loop-mediated isothermal amplification (LAMP), which perform amplification and detection of target gene in a single step by incubating the mixture of sample, primers, DNA polymerase with strand displacement activity and substrates at a constant temperature (in the region of 65 °C), was also used for the specific detection of Legionella spp. in the samples based on their 16 S rRNA sequence (Loopamp Legionella Detection Kit E; Eiken Chemical; http://loopamp.eiken.co.jp/e/products/legionella_e/). Amplification of target gene was monitored by a realtime turbidimeter (LA-320C; Eiken Chemical).

Fluorescent antibody and blocking solution

An anti-L. pneumophila antibody (6051; ViroStat, Portland, ME, USA) was labelled with an Alexa Flour 488 Protein Labelling Kit (Thermo Fisher Scientific, Waltham, MA, USA) according to the manufacturer’s instructions.

Blocking solution for antibody staining of Legionella cells was prepared with bovine serum albumin (BSA; Wako Pure Chemical Industries, Osaka, Japan); BSA was dissolved in PBS (final concentration: 12%) and filtered through a 0.2-μm-pore-size filter just before use to remove small particles.

Fluorescence microscopy

The number of L. pneumophila in each sample was determined by fluorescence microscopy to obtain precise bacterial numbers to compare to the number determined by the microfluidic system. For blocking, BSA was added to the sample at 3% (w/v) and incubated for 15 min at room temperature (approximately 25 °C). Then, fluorescent antibody (final concentration: 4 μg/ml) was added and cells were stained for 15 min at room temperature in the dark. Stained cells in the sample were filtered onto a black polycarbonate membrane filter (pore size: 0.2 μm, diameter: 25 mm; Advantec). The stained cells were counted at a magnification of 1000X(objective lens: Plan Fluor 100X; Nikon, Tokyo, Japan) under blue excitation (Nikon B-2A cube; excitation filter EX 450–490, dichroic mirror DM 505, absorption filter BA 520) using an epifluorescent microscope (E-800; Nikon).

Microfluidic device designed for “on-chip” staining and counting

Polydimethylsiloxane (PDMS)-glass hybrid microfluidic devices were constructed using rapid prototyping and replica-moulding techniques24. The masks for the channel patterns were printed onto transparent film. Ultra-thick photoresist film (SU-8-50; Microchem, Newton, MA, USA) was spin-coated onto a silicon wafer and baked on a hot plate at 65 °C for 2 min and 95 °C for 3 min. The pattern on the mask was photolithographically transferred to the SU-8-coated silicon wafer using a mask aligner (M-1S; Mikasa, Tokyo, Japan). After development in SU-8 developer (Microchem) for 3 min, the master was washed in isopropyl alcohol and then distilled water. The prepolymer of PDMS and the curing agent (Silpot 184; Toray Dow Corning, Tokyo, Japan) were mixed at a ratio of 10:1, stirred thoroughly, and then degassed under vacuum. The prepolymer mixture was poured onto the master and cured at 120 °C for 40 min. After being cured, the PDMS replica was peeled off from the master. Access ports were drilled into the device by a paper punch (diameter, 2 mm). The PDMS replica was attached to a cover glass using a plasma reactor (SEDE/V; Meiwa Fosis, Osaka, Japan). Each sample was mixed with BSA (final concentration 6%), and 20 μg/ml of fluorescent antibody and sheath fluid (particle-free water) were injected at each inlet (Fig. 1). The depth of the microchannel was 15 μm and the width was 100 μm, with the exception of the “mixing part” (500-μm width).

Portable microfluidic system

Samples and staining fluid were placed in 100 μl gastight syringes (1710LT; Hamilton, Reno, NV, USA) and sheath fluid was placed in 1-ml gastight syringes (1001LT; Hamilton). These fluids were injected into the microfluidic device via Teflon tubes by the syringe pumps of the system (Fig. 2). Stained cells flowing in the microchannel were monitored through an objective lens (UPlanApo 40X; numerical aperture: 0.85; OLYMPUS, Tokyo, Japan) under blue excitation by a diode laser (wavelength: 473 nm; power: 60 mW) and recorded as a video using a CCD camera (WAT-902H2; Watec, Yamagata, Japan) for 10–15 min per sample. A filter block for an epifluorescent microscope was equipped to detect signals from the fluorescent antibody selectively (Olympus U-MNB2 cube consisted of a dichroic mirror 520IF and absorption filter 500). The flow rate was 0.01 μl/min for the sample and staining fluid, compared with 0.005 μl/min for the sheath fluid. Flowing cells in the movie were processed and counted using image analysis software (BADICS-FCM; Lambda Vision, Kanagawa, Japan), which can enhance positive signals and discriminate background fluorescence by binarisation. The number of L. pneumophila in each sample was calculated as cells/ml, as determined from the cell count and flow volume.